Migi (Cat) Feline Pancreatic Lipase (fPL) Rapid Quantitative Test Kit

Notice: You need an Immunofluorescence Analyzer to run the tests with this kit

Contact us for the equipment and test kits combo wholesale

SPECIFICATION

10 Test/Box

Cat.No.:MG-CA-R015

INTENDED USE

The fPL test is a fluorescence immunoassay used along with an Immunofluorescence Analyzer for the quantitative determination of pancreatic lipase concentration in serum, or plasma. This test is used to diagnose and monitor the level of pancreatic lipase in feline.

For in vitro diagnostic use only. For professional use only.

TEST PRINCIPLE

1. This test employs a quantitative double antibody sandwich fluorescence immunoassay technique.

2. The fluorescent signal intensity reflects the amount of fPL captured. The concentration is expressed as Tu/ml.

MATERIAL

STORAGE AND STABILITY

1. Store the test kit at 4～30℃ up to the expiration date.
2. The test should operate at 18 ~ 28℃ after the Test Device opening.
3. Once the pouch is opened, the test should be performed within 30 minutes.

SPECIMEN COLLECTION AND PREPARATION

The test can be performed with serum or plasma.

1. Separate serum or plasma (EDTA anticoagulant is recommended) from blood within 3 hours after blood collection. If a specimen appears to be severely hemolyzed, another specimen should be obtained and tested.

2. Optimally, the test should be performed immediately after the specimen collection. If the test cannot be performed within 3 hours after blood collection, store the specimen at 2～8℃ for no longer than 72 hours. For long-term storage, specimens shall be kept below -20℃.

Bring all materials to room temperature before use. Frozen specimens must be completely thawed and mixed well prior to testing. Specimens should not be frozen and thawed repeatedly. Only clear, non-hemolyzed specimens can be used.

TEST PROCEDURE

Refer to the Immunofluorescence Analyzer Operation Manual for complete instructions for use of the Test device.

1. Set a Test Device on a clean, level horizontal table.
2. Insert the ID Chip into the meter, and click “Read ID chip”. Make sure that the Test Device lot No. matches with ID Chip No.

3. Pipette 50 μl of prepared sample into the fPL Sample Buffer, and gently mix well. Vigorous agitation and foaming should be avoided.

4. Pipette 100 μl of mixed sample to add into the sample of the

test device. Avoid forming bubbles.

5. Test mode: a or b

a) Standard Test: Click “Standard Test”, insert the Test Device into the device holder of the meter right after adding the sample to the sample well, and click “Start Test”. The meter will start to countdown and read the test result automatically.

b) Quick Test: Click “Quick Test”, and start the timer right after adding the sample mixture to the sample well. Leave the Test Device at room temperature (18 ~ 28℃) for 15 minutes. Then insert the test device immediately into the holder of the meter and click “Start Test”. The instrument will scan the Test Device automatically and show the test result.

6. Results are displayed on the main screen, print automatically, or be printed by clicking “Print”.

QUALITY CONTROL

Each fPL Rapid Quantitative Test contains an internal control for routine quality control requirements. This internal quality control is performed each time a patient sample is tested, If an invalid result from the internal control occurs, the meter will display an error message, indicating that another test should be conducted.

INTERPRETATION

Reference range of fPL in feline serum or plasma.

1. Detection range: 2.0 ~ 224 ng/ml
2. Reference:

Each laboratory should establish a reference range that is representative of the population to be evaluated.

WARNINGS AND LIMITATIONS OF THE PROCEDURE

1. This kit is for in vitro diagnostic use only.
2. Inspect the packaging and labels before use. Do not use it if the pouch is broken, torn, or not well sealed, or if the vial looks damaged or leaked.
3. Do not use the test device beyond the expiration date.
4. One pipette tip should be used for one specimen only.
5. There is the possibility that factors such as technical or procedural errors, as well as additional substances in blood specimens that are not listed in the text, may interfere with the test and cause erroneous results.